Impactiviti Daily – A Friday Stroll

Yes, I know, this is usually a pharma news post. But you know what? It’s the Friday before a holiday weekend, and a gorgeous morning yielded some lovely pictures of a backyard stroll today. So, forget drug news. Here’s a visual jump-start for your pending weekend: Oh, and if you haven’t seen it yet – [...]

Read Full Post »

Impactiviti Daily 052710 Top Pharma News

***** Impactiviti has launched a new venture, and we’d like to ask for your help to make it a success! Introducing the Impactiviti Talent Network – on-line job search joined to social networking. This can help you as a job seeker, AND as a company posting openings! TODAY’S NEWS: Head of Pfizer R&D pulls up [...]

Read Full Post »

Impactiviti Daily 052610 Top Pharma News

***** TODAY’S NEWS: Very big news for Vertex – 75% of hepatitis C patients never treated before achieved a viral cure after receiving a 12-week course of the company’s experimental drug telaprevir plus the current standard of care, according to results from a phase III study…more Genzyme’s Pompe remedy approved by FDA; meanwhile, more detail [...]

Read Full Post »

Impactiviti Daily 052510 Top Pharma News

***** TODAY’S NEWS: Watson gets FDA approval to start shipping generic Valtrex. Novartis oral MS drug – FDA extends review another 3 months – Novartis will have to wait a bit longer in its bid to get the first oral treatment for multiple sclerosis on the market after regulators in the USA put back a [...]

Read Full Post »

The Three “I’s” of Tomorrow’s Successful Company

Guest post by Dennis Urbaniak, VP U.S. Diabetes, Sanofi-Aventis Pharmaceuticals Today if you work in corporate America, massive organizational change is the norm.  There are multiple causes in multiple industries but one common theme across all is a glimpse of recognition that companies need to change how they work in order to survive and drive [...]

Read Full Post »

Impactiviti Daily 052410 Top Pharma News

***** TODAY’S NEWS: We’re in the pre-ASCO oncology news build-up phase. Here’s a brief preview. And even more here. Does HGH really help athletes? Interesting article – the last paragraph is the kicker. Whistleblowers (J&J) get a payday. And, allegations about illegal sales practices by Roche with Tamiflu. RECOMMENDED eLearning. We know that space inside [...]

Read Full Post »

“So, What’s Your Problem with Gram-Negative Bacteria??”

-by Bruce G.N. Bacterium, Esq. It’s really unfair. All this bad press about gram-negative bacteria. Would you feel different if we were gram-positive? Well? Would you? Here we are, just bumping along, doing a little harmless infecting of human hosts, and WHAM! – we’re suddenly the bad guy in all the newspapers. So we occupy [...]

Read Full Post »

Impactiviti Daily 052110 Top Pharma News

***** TODAY’S NEWS: Abbott making a big India buy – The speculation that has been fuelling the shares of Piramal Healthcare over the past few days has been put to rest after Abbott Laboratories announced Friday that it will buy a unit of the Indian pharmaceutical company…more Lots of Oncology. Rituxan: cutting lymphoma recurrence – [...]

Read Full Post »

Impactiviti Daily 052010 Top Pharma News

***** TODAY’S NEWS Novartis: huge punitive fine in discrimination case. $250 million game-changing dollars. FDA to the public – let’s talk more. Or, tell us more about what we should tell you. GSK and more Avandia flak. This story will never end, it seems. Pfizer and multiple corporate cultures. An interesting interview at Forbes magazine. [...]

Read Full Post »

Impactiviti Daily 051910 Top Pharma News

***** TODAY’S NEWS Sometimes I can’t help but voice a bit of skepticism, especially when it comes to sexual disorder treatments. So, count me as less than convinced about this experimental treatment from Boehringer-Ingelheim – Data from pivotal Phase III clinical trials demonstrate that a higher proportion of pre-menopausal women with Hypoactive Sexual Desire Disorder [...]

Read Full Post »